AzTrials
AzTrials

Critical IllnessVRCycling-ICUNCT07894146

Cycling Within an Interactive and Immersive Virtual Environment During Critical Illness: a Patient-centred Approach for Lower Limb Rehabilitation

A study testing Basic-Cycle, TV-Cycle and VR-Cycle in people with Critical Illness, run by KU Leuven at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to investigate whether combining cycling exercise with an immersive and interactive virtual reality (VR) environment improves motivation compared with cycling without visual support or cycling while watching a route on a television screen in critically ill patients admitted to the intensive care unit… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness
What is being tested?
Basic-Cycle, TV-Cycle and VR-Cycle
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteBelgium
Study dates
29 Jun 2026to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Admission to ICU ≥ 7 days
  • ≥ 48h mechanical ventilation
  • Expected additional ICU stay ≥ 7 more days
  • Adult (≥18y)
  • Awake and adequate
  • Alert and calm (RASS -1 to +1)
  • No medical contraindication for (bed-/chair-)cycling
  • Able to perform 10 minutes of active cycling

Who cannot join

  • Significant visual impairments
  • Cognitive impairment (MMSE < 20/30)
  • Psychotic disorder
  • Pregnancy
  • Not able to understand Dutch, French or English
  • Not able to provide informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Daniel Langer, Associate professor contact

+32 16 34 71 25

daniel.langer@kuleuven.be

Belgium1 site, 1 recruiting
  • University Hospitals Leuven

    Leuven, 3000

    Daniel Langer, +32 16 34 71 25, daniel.langer@kuleuven.be

    Recruiting

Other trials in Belgium

About this study

This study aims to investigate whether combining cycling exercise with an immersive and interactive virtual reality (VR) environment improves motivation compared with cycling without visual support or cycling while watching a route on a television screen in critically ill patients admitted to the intensive care unit (ICU).

This randomized, within-subject crossover study will include 20 adult ICU patients who have been admitted for at least 7 days, have received mechanical ventilation for at least 48 hours, and are able to perform active cycling exercise.

Read more

Each participant will complete three 10-minute cycling sessions under different conditions: (1) cycling without visual support (Basic-Cycle), (2) cycling while watching a cycling route on a television screen (TV-Cycle), and (3) cycling within an immersive, interactive VR environment (VR-Cycle). The three conditions will be performed in random order over three consecutive days, with the cycling resistance kept constant across conditions for each participant.

The primary outcome is intrinsic motivation, assessed using the Situational Motivation Scale (SIMS). Secondary outcomes include other dimensions of motivation, perceived dyspnea, lower limb fatigue, pain, cycling distance, and safety measures, including vital signs and adverse events.

This study will provide insight into the potential of VR-assisted cycling to improve patient motivation and engagement during early rehabilitation in the ICU.

Being tested
Basic-Cycle, TV-Cycle, VR-Cycle
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Basic-CycleBehavioural

    Cycling without visual support

  • TV-CycleBehavioural

    Cycling while viewing a cycling route on an external television screen

  • VR-CycleBehavioural

    Cycling within an immersive, interactive virtual reality environment

Study groups in NCT07894146
Study groupRoleWhat they receive
Sequence 1: Basic-Cycle / TV-Cycle / VR-CycleExperimentalNot described
Receives: Behavioral: Basic-Cycle; Behavioral: TV-Cycle; Behavioral: VR-Cycle
Sequence 2: Basic-Cycle / VR-Cycle / TV-CycleExperimentalNot described
Receives: Behavioral: Basic-Cycle; Behavioral: TV-Cycle; Behavioral: VR-Cycle
Sequence 3: TV-Cycle / VR-Cycle / Basic-CycleExperimentalNot described
Receives: Behavioral: Basic-Cycle; Behavioral: TV-Cycle; Behavioral: VR-Cycle
Sequence 4: TV-Cycle / Basic-Cycle / VR-CycleExperimentalNot described
Receives: Behavioral: Basic-Cycle; Behavioral: TV-Cycle; Behavioral: VR-Cycle
Sequence 5: VR-Cycle / Basic-Cycle / TV-CycleExperimentalNot described
Receives: Behavioral: Basic-Cycle; Behavioral: TV-Cycle; Behavioral: VR-Cycle
Sequence 6: VR-Cycle / TV-Cycle / Basic-CycleExperimentalNot described
Receives: Behavioral: Basic-Cycle; Behavioral: TV-Cycle; Behavioral: VR-Cycle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intrinsic Motivation

    Self-reported patient-reported outcome measured using the Intrinsic Motivation subscale of the Situational Motivation Scale (SIMS). It consists of four items rated on a 7-point Likert scale, ranging from 1 (does not correspond at all) to 7 (corresponds exactly). The subscale score is calculated as the mean of the four items, ranging from 1 to 7. Higher scores indicate greater intrinsic motivation and therefore a more favorable outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

Secondary outcomes (7)
  1. Dyspnea

    Dyspnea sensation is assessed using the Modified Borg Dyspnea Scale (Borg CR10 Scale). This patient-reported scale measures the perceived intensity of breathlessness during cycling. Scores range from 0 (no breathlessness at all) to 10 (maximal breathlessness). Higher scores indicate greater perceived dyspnea and therefore a worse outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

  2. Lower limb fatigue

    Lower limb fatigue is assessed using the Modified Borg Dyspnea Scale (Borg CR10 Scale). This patient-reported scale measures the perceived intensity of leg fatigue during cycling. Scores range from 0 (no fatigue at all) to 10 (maximal fatigue). Higher scores indicate greater perceived lower limb fatigue and therefore a worse outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

  3. Pain

    Pain perception is assessed using the Visual Analog Scale (VAS). This patient-reported scale measures the perceived intensity of pain during cycling. Scores range from 0 (no pain at all) to 10 (worst imaginable pain). Higher scores indicate greater perceived pain intensity and therefore a worse outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

  4. Cycle distance

    An estimated cycle distance will be recorded during each cycling condition by the cycle ergometer in meters

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

  5. Identified Regulation

    Self-reported patient-reported outcome measured using the Identified Regulation subscale of the Situational Motivation Scale (SIMS). It consists of four items rated on a 7-point Likert scale, ranging from 1 (does not correspond at all) to 7 (corresponds exactly). The subscale score is calculated as the mean of the four items, ranging from 1 to 7. Higher scores indicate greater identified regulation, reflecting more autonomous motivation and therefore a more favorable outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

  6. External Regulation

    Self-reported patient-reported outcome measured using the External Regulation subscale of the Situational Motivation Scale (SIMS). It consists of four items rated on a 7-point Likert scale, ranging from 1 (does not correspond at all) to 7 (corresponds exactly). The subscale score is calculated as the mean of the four items, ranging from 1 to 7. Higher scores indicate greater externally controlled motivation, reflecting less autonomous motivation and therefore a less favorable outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

  7. Amotivation

    Self-reported patient-reported outcome measured using the Amotivation subscale of the Situational Motivation Scale (SIMS). It consists of four items rated on a 7-point Likert scale, ranging from 1 (does not correspond at all) to 7 (corresponds exactly). The subscale score is calculated as the mean of the four items, ranging from 1 to 7. Higher scores indicate greater amotivation and therefore a less favorable outcome.

    Measured: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start29 Jun 2026
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Within-subject cross-over study design
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07894146
Sponsor's protocol ID
S71922
Acronym
VRCycling-ICU
Status last verified
Oct 2026
First submitted
12 Oct 2026
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Basic-Cycle, TV-Cycle and VR-Cycle in people with Critical Illness, run by KU Leuven at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Daniel Langer, Associate professor (+32 16 34 71 25, daniel.langer@kuleuven.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intrinsic Motivation (time frame: Assessed following each cycling condition (max 20min cycling), on day 1, day 2 and day 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in